Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04722185
NCT04722185CompletedNot Applicable

Evaluation of the Veriton SPECT/CT System

Mayo Clinic1 site in 1 country41 target enrollmentStarted: January 20, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
41
Locations
1
Primary Endpoint
Image quality
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The main purpose of this study is to evaluate a new type of gamma camera (the Veriton system) that provides a significant gain in system sensitivity and improved image quality compared to a conventional gamma camera that can achieve equal or better image quality than a standard SPECT/CT system.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults age 18 years or older.
  • •Currently scheduled to undergo a nuclear medicine exam.

Exclusion Criteria

  • •Individuals under 18 years of age.
  • •Unwilling/unable to sign an informed consent form.
  • •Unable to lie on a Veriton imaging table for up to 40 minutes.

Arms & Interventions

Evaluation of the Veriton SPECT/CT system

Experimental

To determine if the Veriton system can achieve equal or better image quality than a standard SPECT/CT system.

Intervention: Veriton SPECT/CT (Diagnostic Test)

Outcomes

Primary Outcomes

Image quality

Time Frame: 1 year

Assessment of relative image quality between the Veriton system and a conventional gamma camera as a function of the type of nuclear medicine exam.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Carrie Hruska

Principal Investigator

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
Demonstration Of A Next Generation PET CT SystemOncology
NCT05122715GE Healthcare70
Completed
Phase 3
Intraoperative Gamma Camera for Breast Cancer SurgeryDuctal Carcinoma in SituBreast Cancer
NCT00757302University Hospital, Strasbourg, France110
Completed
Not Applicable
Demonstration of the "SPECT/CT System With CZT Detectors" Imaging Performance in a Clinical SettingCancer
NCT03229772GE Healthcare19
Recruiting
Not Applicable
Comparison of Record in VERITON Camera to the Anger Camera Procedure in Patients Treated by 131-iodineDevice
NCT05713123Central Hospital, Nancy, France77
Recruiting
Not Applicable
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment OptimizationAdvanced CancerProstate Cancer
NCT06389097Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins80